Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
1017185-91-9
61887-91-0
1134723-32-2
1282118-47-1
863667-96-3 | 3-[(3,4-difluorophenyl)sulfanyl]propanoic acid | AA019OGN | MFCD07339036
871544-51-3 | 5-methyl-2-(1-methyl-1H-pyrrol-2-yl)azepane | AA019ONU | MFCD07352300
24652-61-7 | N-{[2-(trifluoromethyl)phenyl]methylidene}hydroxylamine | AA019OTN | MFCD03015196
175154-40-2 | 1-[(2-chloroethyl)sulfanyl]-2-fluorobenzene | AA019P1M | MFCD06671624
923146-35-4 | 2-chloro-N-[2-methyl-4-(pyrrolidin-1-yl)phenyl]acetamide | AA019P9G | MFCD08691096
885529-55-5 | 1-(Bromomethyl)-4-((difluoromethyl)sulfonyl)benzene | AA019PFX | MFCD08444195
923171-84-0 | 1-(2-chloroacetyl)-N-phenylpiperidine-4-carboxamide | AA019PMJ | MFCD08444301
1354960-73-8 | 2-methyl-6-nitro-4-(1,2,3,6-tetrahydropyridin-4-yl)aniline hydrochloride | AA019PQP | MFCD20441560
1354951-39-5 | 4-(3-methanesulfonylpropoxy)-2,3-dihydro-1H-inden-1-ol | AA019QIA | MFCD18546433
1087788-91-7 | 2,2,2-trifluoroethyl N-(5-chloro-2-methoxyphenyl)carbamate | AA019QSB | MFCD11099857
868376-32-3
477505-08-1
Journal: Bioorganic & medicinal chemistry letters20101101